CVKD
Cadrenal Therapeutics, Inc.
Latest Form 4:Sale$22KbyPham Quang X (Chairman and CEO) · filed Jul 2, 2026
Cadrenal Therapeutics, Inc. (CVKD) has 21 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
The most active filer is Chairman and CEO Pham Quang X with 31 filings. Insiders have net sold $388K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Quang X. Pham
- Employees:4
- HQ:Ponte Vedra, FL, US
- IPO:2023-01-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1000K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$5.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chairman and CEO | Sale | 7,400 | $22K | Jul 2 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,127 | $6K | Jun 27 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,029 | $28K | Jun 27 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,167 | $33K | Jun 24 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,277 | $7K | Jun 24 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,613 | $11K | Jun 18 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 513 | $2K | Jun 18 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 1,462 | $6K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,996 | $51K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,666 | $13K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 5,893 | $26K | Jun 11 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,992 | $53K | Jun 11 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,500 | $15K | Jun 11 | SEC ↗ | |
| CEO and Chairman | Sale | 2,323 | $10K | Jun 5 | SEC ↗ | |
| CEO and Chairman | Sale | 3,898 | $17K | Jun 5 | SEC ↗ | |
| CEO and Chairman | Sale | 2,064 | $9K | Jun 5 | SEC ↗ | |
| CEO and Chairman | Sale | 303 | $2K | Jun 3 | SEC ↗ | |
| CEO and Chairman | Sale | 349 | $2K | Jun 3 | SEC ↗ | |
| CEO and Chairman | Sale | 6,476 | $37K | May 29 | SEC ↗ | |
| CEO and Chairman | Sale | 3,298 | $17K | May 29 | SEC ↗ | |
| CEO and Chairman | Sale | 2,989 | $15K | May 29 | SEC ↗ | |
Pham Quang XFirst in 7 months | CEO and Chairman | Sale | 1,165 | $7K | May 27 | SEC ↗ |
| Chief Financial Officer | Sale | 9,933 | $69K | Dec 31 | SEC ↗ | |
| CEO and Chairman | Sale | 1,129 | $16K | Oct 28 | SEC ↗ | |
| CEO and Chairman | Sale | 1,315 | $18K | Oct 28 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,800 | $25K | Oct 28 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,800 | $25K | Oct 28 | SEC ↗ | |
| CEO and Chairman | Sale | 1,800 | $25K | Oct 14 | SEC ↗ | |
| CEO and Chairman | Sale | 1,800 | $25K | Oct 14 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,693 | $24K | Oct 14 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,800 | $25K | Oct 14 | SEC ↗ | |
| Chief Financial Officer | Sale | 107 | $1K | Oct 7 | SEC ↗ | |
| CEO and Chairman | Sale | 500 | $7K | Oct 3 | SEC ↗ | |
| CEO and Chairman | Sale | 419 | $6K | Oct 1 | SEC ↗ | |
| CEO and Chairman | Sale | 881 | $12K | Oct 1 | SEC ↗ | |
| Chief Financial Officer | Sale | 100 | $1K | Oct 1 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,700 | $24K | Oct 1 | SEC ↗ | |
Szot Matthew KFirst filing | Chief Financial Officer | Sale | 1,500 | $21K | Sep 26 | SEC ↗ |
Szot Matthew KFirst filing | Chief Financial Officer | Sale | 10,900 | $153K | Sep 26 | SEC ↗ |
Pham Quang XFirst filing | CEO and Chairman | Sale | 2,581 | $36K | Sep 26 | SEC ↗ |
Pham Quang XFirst filing | CEO and Chairman | Sale | 6,790 | $96K | Sep 26 | SEC ↗ |
Related companies
Cadrenal Therapeutics, Inc. is in the Healthcare sector.